JP2018077253A5 - - Google Patents

Download PDF

Info

Publication number
JP2018077253A5
JP2018077253A5 JP2018004851A JP2018004851A JP2018077253A5 JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5 JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5
Authority
JP
Japan
Prior art keywords
mass spectrometry
liquid chromatography
amount
ionization
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018004851A
Other languages
English (en)
Japanese (ja)
Other versions
JP6821610B2 (ja
JP2018077253A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018077253A publication Critical patent/JP2018077253A/ja
Publication of JP2018077253A5 publication Critical patent/JP2018077253A5/ja
Application granted granted Critical
Publication of JP6821610B2 publication Critical patent/JP6821610B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018004851A 2014-05-12 2018-01-16 質量分析によるタモキシフェンおよびその代謝産物の定量化 Active JP6821610B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461992214P 2014-05-12 2014-05-12
US61/992,214 2014-05-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016567654A Division JP6279104B2 (ja) 2014-05-12 2015-05-12 質量分析によるタモキシフェンおよびその代謝産物の定量化

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021000689A Division JP2021073450A (ja) 2014-05-12 2021-01-06 質量分析によるタモキシフェンおよびその代謝産物の定量化

Publications (3)

Publication Number Publication Date
JP2018077253A JP2018077253A (ja) 2018-05-17
JP2018077253A5 true JP2018077253A5 (cg-RX-API-DMAC7.html) 2018-06-28
JP6821610B2 JP6821610B2 (ja) 2021-01-27

Family

ID=54367635

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016567654A Active JP6279104B2 (ja) 2014-05-12 2015-05-12 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2018004851A Active JP6821610B2 (ja) 2014-05-12 2018-01-16 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2021000689A Pending JP2021073450A (ja) 2014-05-12 2021-01-06 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2023080724A Pending JP2023109874A (ja) 2014-05-12 2023-05-16 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2025018885A Pending JP2025081382A (ja) 2014-05-12 2025-02-07 質量分析によるタモキシフェンおよびその代謝産物の定量化

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016567654A Active JP6279104B2 (ja) 2014-05-12 2015-05-12 質量分析によるタモキシフェンおよびその代謝産物の定量化

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021000689A Pending JP2021073450A (ja) 2014-05-12 2021-01-06 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2023080724A Pending JP2023109874A (ja) 2014-05-12 2023-05-16 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2025018885A Pending JP2025081382A (ja) 2014-05-12 2025-02-07 質量分析によるタモキシフェンおよびその代謝産物の定量化

Country Status (9)

Country Link
US (6) US9459267B2 (cg-RX-API-DMAC7.html)
EP (2) EP3143392B1 (cg-RX-API-DMAC7.html)
JP (5) JP6279104B2 (cg-RX-API-DMAC7.html)
CN (2) CN110044998B (cg-RX-API-DMAC7.html)
AU (6) AU2015259294A1 (cg-RX-API-DMAC7.html)
BR (1) BR112016026459B1 (cg-RX-API-DMAC7.html)
CA (1) CA2948823C (cg-RX-API-DMAC7.html)
SA (1) SA516380291B1 (cg-RX-API-DMAC7.html)
WO (1) WO2015175561A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3486648B1 (en) * 2008-12-24 2025-04-30 Quest Diagnostics Investments Incorporated Mass spectrometry assay for congenital adrenal hyperplasia
CA2948823C (en) * 2014-05-12 2020-09-22 Quest Diagnostics Investments Incorporated Quantitation of tamoxifen and metabolites thereof by mass spectrometry
CN105159539B (zh) * 2015-09-10 2018-06-01 京东方科技集团股份有限公司 可穿戴设备的触控响应方法、装置及可穿戴设备
CN114585915B (zh) 2019-10-10 2024-02-23 瑞泽恩制药公司 用于分析两性电解质批次变化的液相色谱法-质谱法(lc-ms)方法
IL295038A (en) 2020-01-31 2022-09-01 Regeneron Pharma Use of liquid chromatography and mass spectrometry to characterize oligonucleotides
US12105102B2 (en) 2022-03-30 2024-10-01 University Of Utah Research Foundation Methods for quantifying insulin-like growth factor-1 and insulin-like growth factor-2

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5119827A (en) * 1990-09-05 1992-06-09 Board Of Regents, The University Of Texas System Mechanisms of antiestrogen resistance in breast cancer
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
ATE242485T1 (de) 1993-05-28 2003-06-15 Baylor College Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
IES950928A2 (en) * 1995-12-08 1996-02-21 Bunskellig Limited "A process for analysing a fluid"
GB9717926D0 (en) 1997-08-22 1997-10-29 Micromass Ltd Methods and apparatus for tandem mass spectrometry
US6040575A (en) 1998-01-23 2000-03-21 Analytica Of Branford, Inc. Mass spectrometry from surfaces
CN1871517A (zh) * 2002-02-19 2006-11-29 免疫公司 快速有效分离循环癌细胞的方法和试剂
WO2004087123A1 (en) 2003-04-01 2004-10-14 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
EP1952809B1 (en) * 2002-12-18 2017-08-02 Besins Healthcare Luxembourg SARL Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen
JP4555779B2 (ja) * 2003-12-26 2010-10-06 武田薬品工業株式会社 脂質代謝異常症の予測方法
MY145634A (en) * 2003-12-29 2012-03-15 Bristol Myers Squibb Co Pyrrolotriazine compounds as kinase inhibitors
WO2006052921A2 (en) * 2004-11-08 2006-05-18 Eastman Chemical Company Cyclodextrin solubilizers for liquid and semi-solid formulations
US20090291134A1 (en) * 2006-11-21 2009-11-26 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
US8017403B2 (en) * 2007-06-14 2011-09-13 Quest Diagnostics Investments Incorporated Mass spectrometry method for measuring vitamin B6 in body fluid
US20090134325A1 (en) * 2007-11-27 2009-05-28 Goldman Mildred M Methods for detecting estradiol by mass spectrometry
US8916385B2 (en) * 2007-12-13 2014-12-23 Quest Diagnostics Investments, Inc. Methods for detecting estrone by mass spectrometry
US7834313B2 (en) 2008-08-08 2010-11-16 Quest Diagnostics Investments Incorporated Mass spectrometry assay for plasma-renin
IL313131A (en) * 2009-02-11 2024-07-01 Caris Mpi Inc Molecular characterization of tumors
EP2486404B1 (en) * 2009-10-06 2018-08-15 Wisconsin Alumni Research Foundation Metabolic biomarkers of drug-induced cardiotoxicity
WO2012119010A2 (en) * 2011-03-01 2012-09-07 Indiana University Research And Technology Corporation Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer
US8895918B2 (en) * 2011-06-03 2014-11-25 Purdue Research Foundation Ion generation using modified wetted porous materials
CN104203961B (zh) * 2012-03-05 2017-05-17 泽维尔大学 作为用于治疗乳腺癌的基于硼的4‑羟基他莫昔芬和因多昔芬前药
WO2014014279A1 (ko) * 2012-07-17 2014-01-23 서울대학교 산학협력단 질량 스펙트럼의 재현성 향상 방법 및 이를 이용한 정량 분석 방법
CN103494787B (zh) * 2013-07-22 2014-10-29 南通广泰生化制品有限公司 枸橼酸他莫昔芬滴丸
CA2948823C (en) * 2014-05-12 2020-09-22 Quest Diagnostics Investments Incorporated Quantitation of tamoxifen and metabolites thereof by mass spectrometry

Similar Documents

Publication Publication Date Title
JP2018077253A5 (cg-RX-API-DMAC7.html)
Berg et al. 13C labelled internal standards—A solution to minimize ion suppression effects in liquid chromatography–tandem mass spectrometry analyses of drugs in biological samples?
JP2017516104A5 (cg-RX-API-DMAC7.html)
Helm et al. Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomics
Van Belkum et al. Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories
Ramautar et al. CE‐MS in metabolomics
JP2011504596A5 (cg-RX-API-DMAC7.html)
JP2011505013A5 (cg-RX-API-DMAC7.html)
JP2011530701A5 (cg-RX-API-DMAC7.html)
BR112017025097A2 (pt) método para quantificação espectrométrica de massa de analitos extraídos de um dispositivo de microamostragem
EP3570315A3 (en) Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples
WO2006130474A3 (en) Multi-beam ion mobility time-of-flight mass spectrometer with bipolar ion extraction and zwitterion detection
WO2015184321A3 (en) Rare molecule detection
JP2012504766A5 (cg-RX-API-DMAC7.html)
Chingin et al. Rapid recognition of bacteremia in humans using atmospheric pressure chemical ionization mass spectrometry of volatiles emitted by blood cultures
Wong et al. Advances in rapid detection of SARS-CoV-2 by mass spectrometry
SA516380291B1 (ar) الحساب الكمي لتاموكسيفين ونواتج أيضه بواسطة القياس الطيفي الكتلي
Pinto et al. Identification of SARS-CoV-2 proteins from nasopharyngeal swabs probed by multiple reaction monitoring tandem mass spectrometry
Meisen et al. Direct coupling of high-performance thin-layer chromatography with UV spectroscopy and IR-MALDI orthogonal TOF MS for the analysis of cyanobacterial toxins
KR101516086B1 (ko) 대사체 분석을 이용한 류마티스 관절염 진단방법
Liu et al. Matrix effects in the liquid chromatography-tandem mass spectrometry method of analysis
Kailasa et al. Electrospray ionization tandem mass spectrometry for rapid, sensitive and direct detection of melamine in dairy products
Ishii et al. Simple and sensitive determination of α-and β-amanitin by liquid chromatography–quadrupole time-of-flight mass spectrometry
Rincón et al. Evaluation of peripheral blood microsampling techniques in combination with liquid chromatography‐high resolution mass spectrometry for the determination of drug pharmacokinetics in clinical studies
Schreiber et al. LC-MS/MS analysis of emerging food contaminants